SightLine Partners LLC 4
4 · VAPOTHERM INC · Filed Nov 20, 2018
Insider Transaction Report
Form 4
VAPOTHERM INCVAPO
SightLine Partners LLC
10% Owner
Transactions
- Conversion
Series D Convertible Preferred Stock
2018-11-16−314,109→ 0 total→ Common Stock (314,109 underlying) - Conversion
Common Stock
2018-11-16+35,713→ 1,298,217 total - Conversion
Series A Convertible Preferred Stock
2018-11-16−372,206→ 0 total→ Common Stock (372,206 underlying) - Conversion
Series C Convertible Preferred Stock
2018-11-16−430,937→ 0 total→ Common Stock (430,937 underlying) - Conversion
Common Stock
2018-11-16+1,262,504→ 1,262,504 total - Conversion
Series B Convertible Preferred Stock
2018-11-16−145,252→ 0 total→ Common Stock (145,252 underlying) - Conversion
Series D-1 Convertible Preferred Stock
2018-11-16−35,713→ 0 total→ Common Stock (35,713 underlying)
Footnotes (7)
- [F1]Upon closing of the Issuer's initial public offering, each share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into one share of Common Stock without payment or further consideration. There was no expiration date for the Series A Convertible Preferred Stock, the Series B Convertible Preferred Stock, the Series C Convertible Preferred Stock or the Series D Convertible Preferred Stock.
- [F2]Consists of (i) 163,365 shares held by SightLine Healthcare Opportunity Fund II, (ii) 56,994 shares held by SightLine Healthcare Opportunity Fund II-A and (iii) 151,847 shares held by SightLine Healthcare Opportunity Fund II-B.
- [F3]Consists of (i) 63,753 shares held by SightLine Healthcare Opportunity Fund II, (ii) 22,241 shares held by SightLine Healthcare Opportunity Fund II-A and (iii) 59,258 shares held by SightLine Healthcare Opportunity Fund II-B.
- [F4]Consists of (i) 189,144 shares held by SightLine Healthcare Opportunity Fund II, (ii) 65,986 shares held by SightLine Healthcare Opportunity Fund II-A and (iii) 175,807 shares held by SightLine Healthcare Opportunity Fund II-B.
- [F5]Consists of (i) 137,866 shares held by SightLine Healthcare Opportunity Fund II, (ii) 48,098 shares held by SightLine Healthcare Opportunity Fund II-A and (iii) 128,145 shares held by SightLine Healthcare Opportunity Fund II-B.
- [F6]Upon closing of the Issuer's initial public offering, each share of Series D-1 Convertible Preferred Stock automatically converted into 1.137 shares of Common Stock without payment or further consideration. There was no expiration date for the Series D-1 Convertible Preferred Stock.
- [F7]Consists of 35,713 shares held by SightLine Investors, LLC.